Organization | Field Name | ID | Required |
---|---|---|---|
KCR | Scope Regional LN (STORE) (FordsRegLNSurg) | 50110 | yes |
NAACCR | RX Summ--Scope Reg LN Sur | yes |
Field Length: 1
Record the removal, biopsy, or aspiration of regional lymph node(s) at the time of surgery of the primary site or during a separate surgical event.
Code | Label | Description |
---|---|---|
0 | None | No regional lymph node surgery. No lymph nodes found in the pathologic specimen. Diagnosed at autopsy |
1 | Biopsy or aspiration of regional lymph node, NOS | Biopsy or aspiration of regional lymph node(s) regardless of the extent of involvement of disease. |
2 | Sentinel lymph node biospy | Biopsy of the first lymph node or nodes that drain a defined area of tissue within the body. Sentinel node(s) are identified by the injection of a dye or radio label at the site of the primary tumor. |
3 | Number of regional nodes removed unknown or not stated; regional lymph nodes removed, NOS | Sampling or dissection of regional lymph node(s) and the number of nodes removed is unknown or not states. The procedure is not specified as sentinel nodes node biopsy. |
4 | 1-3 regional lymph nodes removed | Sampling or dissection of regional lymph node(s) with fewer than four lymph nodes found in the specimen. The procedure is not specified as sentinel node biopsy. |
5 | 4 or more regional lymph nodes removed | Sampling or dissection of regional lymph nodes with at least four lymph nodes found in the specimen. The procedure is not specified as sentinel node biopsy. |
6 | Sentinel node biopsy and code 3, 4, or 5, at same time, or timing not stated | Code 2 was performed in a single surgical event with code 3, 4, or 5. Or, code 2 and 3, 4, or 5 were performed, but timing was not stated in patient record. |
7 | Sentinel node biopsy and code 3, 4, or 5 at different times | Code 2 was followed in a subsequent surgical event by procedures coded 3, 4, or 5. |
9 | Unknown or not applicable | It is unknown whether regional lymph node surgery was performed; death certificate-only; for lymphomas with a lymph node primary site; an unknown or ill-defined primary; or for hematopoietic, reticuloendothelial, immunoproliferative, or myeloproliferative disease. |